Drug Information

Drug General Information
Drug ID
D02ZPZ
Former ID
DNC003712
Drug Name
5-((E)-Styryl)-quinazoline-2,4-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533781]
Formula
C16H14N4
Canonical SMILES
C1=CC=C(C=C1)C=CC2=C3C(=CC=C2)N=C(N=C3N)N
InChI
1S/C16H14N4/c17-15-14-12(10-9-11-5-2-1-3-6-11)7-4-8-13(14)19-16(18)20-15/h1-10H,(H4,17,18,19,20)/b10-9+
InChIKey
YPIDSPOROIRHIL-MDZDMXLPSA-N
PubChem Compound ID
6532431
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [533781]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 533781J Med Chem. 1995 Mar 3;38(5):745-52.2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
Ref 533781J Med Chem. 1995 Mar 3;38(5):745-52.2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.